Compare · MDLN vs XAIR
MDLN vs XAIR
Side-by-side comparison of Medline Inc. (MDLN) and Beyond Air Inc. (XAIR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and XAIR operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $44.40B, about 8530.3x XAIR ($5.2M).
- Over the past year, MDLN is down 17.1% and XAIR is down 88.9% - MDLN leads by 71.8 points.
- MDLN has been more active in the news (20 items in the past 4 weeks vs 2 for XAIR).
- MDLN has more recent analyst coverage (25 ratings vs 5 for XAIR).
- Company
- Medline Inc.
- Beyond Air Inc.
- Price
- $33.80+0.58%
- $0.41+2.69%
- Market cap
- $44.40B
- $5.2M
- 1M return
- -19.55%
- -17.42%
- 1Y return
- -17.07%
- -88.85%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- News (4w)
- 20
- 2
- Recent ratings
- 25
- 5
Beyond Air Inc.
Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO) generator and delivery systems. The company is developing LungFit system, a NO generator and delivery system, which is in clinical trials for the treatment of persistent pulmonary hypertension of the newborn; acute viral pneumonia, including COVID-19; bronchiolitis and nontuberculous mycobacteria lung infections; and solid tumors. It operates in Israel, Ireland, Australia, and the European Union. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.
Latest MDLN
- Medline Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement
- Large owner Hellman & Friedman Capital Partners X (Parallel), L.P. sold $1,164,385,709 worth of shares (31,868,237 units at $36.54) and disposed of 1,887,801 shares (SEC Form 4)
- Director Healy Patrick J acquired 202,106 shares, increasing direct ownership by 15% to 1,387,921 units (SEC Form 4)
- Large owner Bx Mozart Ml-2 Holdco L.P. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Large owner Bcp 8 Holdings Mozart Manager L.L.C. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Medline's Prime Vendor model expands outside the United States
- Medline Inc. announces closing of upsized secondary offering of Class A common stock
- Medline announces participation in upcoming investor conferences
- MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
- Large owner Bx Mozart Ml-1 Holdco L.P. converted options into 11,348,698 shares and disposed of 11,348,698 units of Class B Common Stock (SEC Form 4)
Latest XAIR
- Beyond Air Inc. filed SEC Form 8-K: Other Events
- Beyond Air Receives Nasdaq Hearing Panel Decision Granting Continued Listing
- Amendment: SEC Form SCHEDULE 13G/A filed by Beyond Air Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by Beyond Air Inc.
- SEC Form DEF 14A filed by Beyond Air Inc.
- SEC Form PRE 14A filed by Beyond Air Inc.
- Beyond Air Inc. filed SEC Form 8-K: Other Events
- Beyond Air to Participate in the D. Boral Capital Global Conference 2026
- Beyond Air Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- Beyond Air Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure